From a laboratory in Tel Aviv, researchers have developed a sixty-dollar blood test capable of detecting advanced lung cancer in more than nine of ten patients — not by reading the genetic code itself, but by reading the chemical annotations written upon it. In a world where lung cancer claims nearly two million lives each year, the significance lies not only in the science but in the accessibility: this test uses equipment already present in most hospitals, asking nothing of the specialized infrastructure that has kept precision diagnostics out of reach for so many. It is an early finding, no
Researchers Develop $60 Blood Test That Detects Advanced Lung Cancer With 93% Accuracy
Lung cancer remains the leading cause of cancer death globally, with 1.9 million deaths annually, making accessible diagnostic tools critical for improving survival rates.